BIOHK2022: Hong Kong needs a more integrated and harmonised ecosystem to become a biotech fundraising hub, panellists say

December 15, 2022 Chin@Strategy

From left, Bin Li of Lake Bleu Capital, Vijay Karwal of AffaMed Therapeutics, Donald Lung, CFO of Antengene and Yinxiang Wang, chairman and CEO of Jacobio Pharma, take part in a panel discussion on ‘Capital Market for Healthcare Post Pandemic’ at BIOHK2022 on Thursday. Photo: Handout

South China Morning Post

Related posts

• 

  August 24, 2025 Media Library 0

  Chinese team to delve into deep history of Egypt’s ancient Sekhmet Temple ruins

  A team led by the Shanghai Museum will embark on a joint archaeological research project with...

• 

  August 24, 2025 Media Library 0

  Chinese ownership of US farmland no threat to American security, envoy says

  China’s top envoy in Washington has rejected suggestions that Chinese ownership of US farmland is a...

• 

  August 23, 2025 Media Library 0

  Taiwanese laptop maker Asus’ subsidiary builds Nvidia-powered supercomputer

  A unit of Taiwanese consumer electronics giant Asus is developing a supercomputer, powered by Nvidia chips,...